- NovoLog® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® or one of its excipients.
NovoPen Echo® Instructions For Use
Important Safety Information
Double click to edit
The content in the shaded area has been supplied by Novo Nordisk and access is restricted to health care professionals only. Novo Nordisk has no control over, and accepts no responsibility or liability for, any other content featured here and gives no representation or warrantly (express or implied) as to the information contained in such content. Further, Novo Nordisk does not recommend or endorse any third party's products or services that may be referred to.